Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis

Journal of Rheumatology

Volumn 25, Issue 3, 1998, Pages 427-432

  Matsuda, Yuko ^a   Yamanaka, Hisashi ^a   Higami, Kenshi ^a   Kashiwazaki, Sadao ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Erosion; Prognosis; Prospective study; Rheumatoid arthritis; Time lag

Indexed keywords

ANTIRHEUMATIC AGENT; AURANOFIN; AUROTHIOMALATE; BUCILLAMINE; C REACTIVE PROTEIN; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISOLONE;

ADULT; ARTICLE; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; POLYARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0031911552     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Smythe CJ. Therapy of rheumatoid arthritis. A pyramidal plan. Postgrad Med J 1972;1:31-9.
2. Tak PP, Taylor PC, Breedveld FC, et al. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1077-81.
3. Joosten LAB, Helsen MMA, van de Loo FAJ, van den Berg WB. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNFα, anti-IL-1α/ß, and IL-1Ra. Arthritis Rheum 1996;39:797-809.
4. Isomaki P, Luukkainen R, Saario R, Toivanen P, Punnonen J. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996;39:386-95.
5. Pasero G, Priolo F, Marubini E, et al. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum 1996;39:1006-15.
6. Conaghan PG, Brooks P. Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine. Curr Opin Rheumatol 1995;7:167-73.
7. Epstein WV. Efficacy of standard slow-acting antirheumatic drugs. Semin Arthritis Rheum 1994;23 Suppl 2:32-8.
8. Emery P. Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive? Br J Rheumatol 1995;34 Suppl 2:87-90.
9. Wilske KR, Healey LA. Remodeling the pyramid - a concept whose time has come [editorial]. J Rheumatol 1989;16:565-7.
10. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the sawtooth strategy. J Rheumatol 1990;17 Suppl 22:12-5.
11. Möttönen T, Paimela L, Ahonen J, Helve T, Hannonen P, Leirisalo-Repo M. Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum 1996;39:996-1005.
12. Fries JF, Williams CA, Ramey DR, Bloch DA. The relative toxicity of alternative therapies for rheumatoid arthritis: implications for the therapeutic progression. Semin Arthritis Rheum 1993;23 Suppl 1:68-73.
13. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines: Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996;39:713-22.
14. Pincus T. Long-term outcomes in rheumatoid arthritis. Br J Rheumatol 1995;34 Suppl 2:59-73.
15. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. Silman AJ. The 1987 revised American Rheumatism Association criteria for rheumatoid arthritis [editorial]. Br J Rheumatol 1988;27:341-3.
18. Edwards J, Silman AJ. ARA criteria for rheumatoid arthritis [letter]. Br J Rheumatol 1989;28:176-7.
19. German Society for Clinical Chemistry. Standard method for determination of alkaline phosphatase activity. J Clin Chem Clin Biochem 1972;10 Suppl:281-91.
20. Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 1940;17:172-88.
21. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiologica Diagnosis 1977;18:481-91.
22. van der Heide A, Remme CA, Hofman DM, Jacobs JWG, Bijlsma JWJ. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38:1466-74.
23. van Leeuwen MA, van der Heijde DMFM, van Rijswijk MH, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21:425-9.
24. van Leeuwen MA, van Rijswijk MH, van der Heijde DMFM, et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 1993;32 Suppl 3:9-13.
25. Devlin J, Gough A, Huissoon A, et al. The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. J Rheumatol 1997;24:9-13.
26. van Zeben D, Hazes JMW, Zwinderman AH, Vandenbroucke JP, Breedveld FC. Factors predicting outcome of rheumatoid arthritis: results of a follow-up study. J Rheumatol 1993;20:1288-96.
27. Scott DL, Dawes PT, Fowler PD, Grindulis KA, Shadforth M, Bacon PA. Anti-rheumatic drugs and joint damage in rheumatoid arthritis. Q J Med 1985;54:49-59.
28. Fuchs HA, Pincus T. Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum 1994;37:470-5.
29. Woolf AD, Hall ND, Goulding NJ, et al. Predictors of the long-term outcome of early synovitis: a 5-year follow-up study. Br J Rheumatol 1991;30:251-4.
30. Gough A, Faint J, Salmon M, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994;37:1166-70.
31. Brennan P, Harrison B, Barrett E, et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ 1996;313:471-6.
32. Chikanza IC, Stein M, Lutalo S, Gibson T. The clinical, serologic and radiologic features of rheumatoid arthritis in ethnic black Zimbabwean and British Caucasian patients. J Rheumatol 1994;21:2011-5.
33. Lau EM, Symmons DP, Croft P. The epidemiology of hip osteoarthritis and rheumatoid arthritis in the Orient. Clin Orthop 1996;323:81-90.
34. Suenaga Y, Yasuda M, Zhao Y, Nonaka S, Zhang F, Nobunaga M. Rheumatoid arthritis in the northeastern area of the People's Republic of China and western Japan. J Clin Rheumatol 1995;14:76-80.